

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axoneme assembly (GO:0035082) | 9.78778680 |
| 2 | left/right pattern formation (GO:0060972) | 9.03705180 |
| 3 | primary alcohol catabolic process (GO:0034310) | 7.80363195 |
| 4 | regulation of cilium movement (GO:0003352) | 7.48495503 |
| 5 | vitamin transmembrane transport (GO:0035461) | 6.76205792 |
| 6 | left/right axis specification (GO:0070986) | 6.43521195 |
| 7 | microtubule bundle formation (GO:0001578) | 6.41080325 |
| 8 | ethanol metabolic process (GO:0006067) | 6.38658812 |
| 9 | ventricular system development (GO:0021591) | 6.35549344 |
| 10 | intraciliary transport (GO:0042073) | 6.19694398 |
| 11 | diterpenoid biosynthetic process (GO:0016102) | 5.98682444 |
| 12 | cilium organization (GO:0044782) | 5.82471523 |
| 13 | cilium assembly (GO:0042384) | 5.69344925 |
| 14 | lung epithelium development (GO:0060428) | 5.62215006 |
| 15 | regulation of synapse structural plasticity (GO:0051823) | 5.34027316 |
| 16 | synaptic transmission, dopaminergic (GO:0001963) | 5.22928741 |
| 17 | one-carbon compound transport (GO:0019755) | 5.15267266 |
| 18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.10019705 |
| 19 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 5.08337521 |
| 20 | tolerance induction (GO:0002507) | 5.05076133 |
| 21 | adenosine receptor signaling pathway (GO:0001973) | 4.99998637 |
| 22 | establishment of apical/basal cell polarity (GO:0035089) | 4.97678131 |
| 23 | ethanol oxidation (GO:0006069) | 4.97113421 |
| 24 | centriole assembly (GO:0098534) | 4.94323508 |
| 25 | locomotory exploration behavior (GO:0035641) | 4.88538244 |
| 26 | protein localization to cilium (GO:0061512) | 4.84408289 |
| 27 | prepulse inhibition (GO:0060134) | 4.76334615 |
| 28 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.75775273 |
| 29 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.69019955 |
| 30 | response to xenobiotic stimulus (GO:0009410) | 4.68402508 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.67603749 |
| 32 | sperm capacitation (GO:0048240) | 4.66528616 |
| 33 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.66196139 |
| 34 | glomerular epithelial cell development (GO:0072310) | 4.64581311 |
| 35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.63181452 |
| 36 | striatum development (GO:0021756) | 4.61364130 |
| 37 | synaptic vesicle maturation (GO:0016188) | 4.57344814 |
| 38 | regulation of microtubule-based movement (GO:0060632) | 4.56509440 |
| 39 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.54046437 |
| 40 | establishment of monopolar cell polarity (GO:0061162) | 4.54046437 |
| 41 | negative regulation of B cell mediated immunity (GO:0002713) | 4.53727521 |
| 42 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.53727521 |
| 43 | cellular component assembly involved in morphogenesis (GO:0010927) | 4.53580614 |
| 44 | microtubule-based movement (GO:0007018) | 4.53510997 |
| 45 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.49926363 |
| 46 | negative regulation of humoral immune response (GO:0002921) | 4.40819002 |
| 47 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.40074538 |
| 48 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.33655790 |
| 49 | terpenoid biosynthetic process (GO:0016114) | 4.30804322 |
| 50 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.30328786 |
| 51 | retinoic acid metabolic process (GO:0042573) | 4.28583382 |
| 52 | auditory behavior (GO:0031223) | 4.28120564 |
| 53 | response to amphetamine (GO:0001975) | 4.25957591 |
| 54 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.24835053 |
| 55 | vocalization behavior (GO:0071625) | 4.22388704 |
| 56 | cilium morphogenesis (GO:0060271) | 4.20602034 |
| 57 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.19995890 |
| 58 | regulation of interleukin-5 production (GO:0032674) | 4.15992744 |
| 59 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.15000669 |
| 60 | cell projection assembly (GO:0030031) | 4.14949064 |
| 61 | cAMP catabolic process (GO:0006198) | 4.08765744 |
| 62 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.07113466 |
| 63 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.07041585 |
| 64 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.01947876 |
| 65 | regulation of germinal center formation (GO:0002634) | 3.98762466 |
| 66 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.98228601 |
| 67 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.94165050 |
| 68 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.92540931 |
| 69 | positive regulation of tolerance induction (GO:0002645) | 3.91977164 |
| 70 | positive regulation of neurotransmitter transport (GO:0051590) | 3.87917707 |
| 71 | dopamine receptor signaling pathway (GO:0007212) | 3.84134939 |
| 72 | regulation of interleukin-13 production (GO:0032656) | 3.83424810 |
| 73 | cyclic nucleotide catabolic process (GO:0009214) | 3.83362783 |
| 74 | response to auditory stimulus (GO:0010996) | 3.79643391 |
| 75 | regulation of female receptivity (GO:0045924) | 3.77202796 |
| 76 | cytoplasmic microtubule organization (GO:0031122) | 3.74835955 |
| 77 | synaptic vesicle exocytosis (GO:0016079) | 3.74775869 |
| 78 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.72866833 |
| 79 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.69192538 |
| 80 | long-term memory (GO:0007616) | 3.67648951 |
| 81 | regulation of synaptic vesicle transport (GO:1902803) | 3.67170260 |
| 82 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.66252077 |
| 83 | neuron-neuron synaptic transmission (GO:0007270) | 3.64918965 |
| 84 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.63597909 |
| 85 | positive regulation of membrane potential (GO:0045838) | 3.63248494 |
| 86 | behavioral response to cocaine (GO:0048148) | 3.59530272 |
| 87 | female mating behavior (GO:0060180) | 3.58921729 |
| 88 | neuronal ion channel clustering (GO:0045161) | 3.56809473 |
| 89 | transmission of nerve impulse (GO:0019226) | 3.53811934 |
| 90 | synaptic transmission, glutamatergic (GO:0035249) | 3.53170310 |
| 91 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.53063952 |
| 92 | neuromuscular process controlling balance (GO:0050885) | 3.52134102 |
| 93 | establishment of planar polarity (GO:0001736) | 3.52082895 |
| 94 | establishment of tissue polarity (GO:0007164) | 3.52082895 |
| 95 | regulation of norepinephrine secretion (GO:0014061) | 3.49940778 |
| 96 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.49055471 |
| 97 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.45567117 |
| 98 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.45567117 |
| 99 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.45335650 |
| 100 | dendritic spine morphogenesis (GO:0060997) | 3.45110324 |
| 101 | exploration behavior (GO:0035640) | 3.42932364 |
| 102 | activation of protein kinase A activity (GO:0034199) | 3.42601465 |
| 103 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.42485145 |
| 104 | neuronal action potential propagation (GO:0019227) | 3.42245826 |
| 105 | negative regulation of inclusion body assembly (GO:0090084) | 3.41647681 |
| 106 | microtubule depolymerization (GO:0007019) | 3.41445922 |
| 107 | regulation of synaptic plasticity (GO:0048167) | 3.39263033 |
| 108 | retinol metabolic process (GO:0042572) | 3.37868703 |
| 109 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.37637121 |
| 110 | detection of calcium ion (GO:0005513) | 3.37341431 |
| 111 | neurotransmitter secretion (GO:0007269) | 3.37128634 |
| 112 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.37112844 |
| 113 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.37112844 |
| 114 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.36261631 |
| 115 | cAMP metabolic process (GO:0046058) | 3.34240738 |
| 116 | primary alcohol metabolic process (GO:0034308) | 3.34216090 |
| 117 | protein localization to synapse (GO:0035418) | 3.29788356 |
| 118 | microtubule polymerization or depolymerization (GO:0031109) | 3.29439276 |
| 119 | negative regulation of catecholamine secretion (GO:0033604) | 3.26679137 |
| 120 | exogenous drug catabolic process (GO:0042738) | 3.25680923 |
| 121 | regulation of neurotransmitter uptake (GO:0051580) | 3.25027776 |
| 122 | mechanosensory behavior (GO:0007638) | 3.23987304 |
| 123 | lateral ventricle development (GO:0021670) | 3.23958162 |
| 124 | regulation of postsynaptic membrane potential (GO:0060078) | 3.23321689 |
| 125 | visual learning (GO:0008542) | 3.22988753 |
| 126 | long-term synaptic potentiation (GO:0060291) | 3.22884208 |
| 127 | positive regulation of smoothened signaling pathway (GO:0045880) | 3.21526374 |
| 128 | regulation of glutamate secretion (GO:0014048) | 3.15127952 |
| 129 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.13002720 |
| 130 | glutamate receptor signaling pathway (GO:0007215) | 3.12248223 |
| 131 | peristalsis (GO:0030432) | 3.10746099 |
| 132 | glutathione derivative biosynthetic process (GO:1901687) | 3.10356782 |
| 133 | glutathione derivative metabolic process (GO:1901685) | 3.10356782 |
| 134 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.06113026 |
| 135 | O-glycan processing (GO:0016266) | 3.04384462 |
| 136 | visual behavior (GO:0007632) | 3.04298968 |
| 137 | behavioral fear response (GO:0001662) | 3.04287735 |
| 138 | behavioral defense response (GO:0002209) | 3.04287735 |
| 139 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.03333491 |
| 140 | membrane hyperpolarization (GO:0060081) | 3.00964774 |
| 141 | axonemal dynein complex assembly (GO:0070286) | 21.4056718 |
| 142 | glutamate secretion (GO:0014047) | 2.99774557 |
| 143 | cAMP biosynthetic process (GO:0006171) | 2.99194639 |
| 144 | long term synaptic depression (GO:0060292) | 2.98513274 |
| 145 | apical protein localization (GO:0045176) | 2.98149549 |
| 146 | membrane depolarization during action potential (GO:0086010) | 2.97507731 |
| 147 | chemosensory behavior (GO:0007635) | 2.97300698 |
| 148 | regulation of microtubule depolymerization (GO:0031114) | 2.96763598 |
| 149 | multicellular organismal water homeostasis (GO:0050891) | 2.96413234 |
| 150 | regulation of Rap GTPase activity (GO:0032317) | 2.94370817 |
| 151 | aldehyde catabolic process (GO:0046185) | 2.93297042 |
| 152 | behavioral response to ethanol (GO:0048149) | 2.92442533 |
| 153 | sperm motility (GO:0030317) | 2.92381886 |
| 154 | serotonin metabolic process (GO:0042428) | 2.92323288 |
| 155 | drinking behavior (GO:0042756) | 2.91743020 |
| 156 | learning (GO:0007612) | 2.90450854 |
| 157 | dendritic spine organization (GO:0097061) | 2.90351757 |
| 158 | fear response (GO:0042596) | 2.90225547 |
| 159 | response to histamine (GO:0034776) | 2.87913092 |
| 160 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.87615468 |
| 161 | regulation of neurotransmitter transport (GO:0051588) | 2.86682674 |
| 162 | negative regulation of amine transport (GO:0051953) | 2.86040393 |
| 163 | smoothened signaling pathway (GO:0007224) | 2.85820873 |
| 164 | lateral sprouting from an epithelium (GO:0060601) | 2.85439976 |
| 165 | positive regulation of synaptic transmission (GO:0050806) | 2.84389391 |
| 166 | membrane depolarization (GO:0051899) | 2.84047778 |
| 167 | regulation of tolerance induction (GO:0002643) | 2.81941114 |
| 168 | determination of left/right symmetry (GO:0007368) | 2.77398989 |
| 169 | progesterone metabolic process (GO:0042448) | 2.77071721 |
| 170 | microtubule-based process (GO:0007017) | 2.70549165 |
| 171 | carnitine metabolic process (GO:0009437) | 2.70230631 |
| 172 | reactive oxygen species biosynthetic process (GO:1903409) | 2.67149837 |
| 173 | ear development (GO:0043583) | 2.67090320 |
| 174 | determination of bilateral symmetry (GO:0009855) | 2.66955452 |
| 175 | regulation of autophagic vacuole assembly (GO:2000785) | 2.64830195 |
| 176 | hydrogen peroxide catabolic process (GO:0042744) | 2.63638947 |
| 177 | oligosaccharide biosynthetic process (GO:0009312) | 2.62821805 |
| 178 | retinal rod cell development (GO:0046548) | 2.62073357 |
| 179 | specification of symmetry (GO:0009799) | 2.60682245 |
| 180 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.58573856 |
| 181 | centriole replication (GO:0007099) | 2.57182027 |
| 182 | excretion (GO:0007588) | 2.57179541 |
| 183 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.55539089 |
| 184 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.54261239 |
| 185 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.54261239 |
| 186 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.53766215 |
| 187 | drug catabolic process (GO:0042737) | 2.53758575 |
| 188 | water homeostasis (GO:0030104) | 2.52004165 |
| 189 | sodium ion homeostasis (GO:0055078) | 2.49990894 |
| 190 | organelle assembly (GO:0070925) | 2.49415159 |
| 191 | phenol-containing compound catabolic process (GO:0019336) | 2.43629751 |
| 192 | negative regulation of microtubule depolymerization (GO:0007026) | 2.39304585 |
| 193 | nonmotile primary cilium assembly (GO:0035058) | 2.38733644 |
| 194 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.36189837 |
| 195 | cilium or flagellum-dependent cell motility (GO:0001539) | 16.7317579 |
| 196 | cilium movement (GO:0003341) | 14.8805350 |
| 197 | motile cilium assembly (GO:0044458) | 14.1750237 |
| 198 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 13.3473717 |
| 199 | epithelial cilium movement (GO:0003351) | 12.9968906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.26416518 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.22290231 |
| 3 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.39056698 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.28993722 |
| 5 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.93840923 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89938221 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79764641 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.70867386 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.70754071 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.69713846 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.67634371 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54642833 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.52664246 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51320166 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44233377 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42703819 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42703819 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40395139 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38638075 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29954421 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21611063 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19320951 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.11798705 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10625678 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09323273 |
| 26 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04946374 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94374561 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.93911036 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93279706 |
| 30 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.82297733 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.82066123 |
| 32 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.80786118 |
| 33 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80618125 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.73507859 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69762381 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67198385 |
| 37 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.66373721 |
| 38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62660168 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60693263 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.60210240 |
| 41 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.59391940 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52339858 |
| 43 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.51006557 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49334170 |
| 45 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45661168 |
| 46 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.43627179 |
| 47 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.42879672 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.42266630 |
| 49 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.41847199 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40755599 |
| 51 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.40401059 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40015213 |
| 53 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.38863284 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37637606 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35820917 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34893007 |
| 57 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.34311392 |
| 58 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.33955420 |
| 59 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.33568978 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32075900 |
| 61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31727136 |
| 62 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31529457 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30812587 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30535246 |
| 65 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.30329959 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30083208 |
| 67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.29616708 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29125931 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28882386 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28404154 |
| 71 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.27533454 |
| 72 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24948723 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23538266 |
| 74 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.23039008 |
| 75 | AR_19668381_ChIP-Seq_PC3_Human | 1.22283229 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22234595 |
| 77 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.22119427 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20550979 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19600515 |
| 80 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.19487579 |
| 81 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18610639 |
| 82 | * P68_20966046_ChIP-Seq_HELA_Human | 1.17260389 |
| 83 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16742387 |
| 84 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.16545054 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16276904 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15890139 |
| 87 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15463971 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14026393 |
| 89 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12982262 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12399105 |
| 91 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11463563 |
| 92 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.10752791 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10660034 |
| 94 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10283127 |
| 95 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.10282809 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09957186 |
| 97 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.09335761 |
| 98 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08713786 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08664725 |
| 100 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.07505546 |
| 101 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06718828 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06424522 |
| 103 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06240955 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06235929 |
| 105 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.06141521 |
| 106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05847654 |
| 107 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05155105 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04721402 |
| 109 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03796165 |
| 110 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03745251 |
| 111 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03744816 |
| 112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03628850 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03446977 |
| 114 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03179193 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03174200 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02541752 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02394479 |
| 118 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02181465 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02102230 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02020244 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01732318 |
| 122 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01723734 |
| 123 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01521335 |
| 124 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01295774 |
| 125 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00561991 |
| 126 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99810872 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99695799 |
| 128 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.99439870 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99100106 |
| 130 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96912035 |
| 131 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96077847 |
| 132 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.96056583 |
| 133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95144313 |
| 134 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94817188 |
| 135 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94055600 |
| 136 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93861084 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93414020 |
| 138 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93341321 |
| 139 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.93166644 |
| 140 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92876836 |
| 141 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92866506 |
| 142 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92212569 |
| 143 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.91865748 |
| 144 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91275156 |
| 145 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.89998446 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89503593 |
| 147 | NFYA_21822215_ChIP-Seq_K562_Human | 0.89439072 |
| 148 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.88819153 |
| 149 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88617795 |
| 150 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88198967 |
| 151 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87646979 |
| 152 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.87283819 |
| 153 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87171627 |
| 154 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86526834 |
| 155 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86460759 |
| 156 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.86319534 |
| 157 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85769741 |
| 158 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.85731857 |
| 159 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85512309 |
| 160 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85186597 |
| 161 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85054166 |
| 162 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.84903934 |
| 163 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.84662666 |
| 164 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84169464 |
| 165 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83959595 |
| 166 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83609991 |
| 167 | NFYB_21822215_ChIP-Seq_K562_Human | 0.83112008 |
| 168 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82782677 |
| 169 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82446192 |
| 170 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.82330356 |
| 171 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82269198 |
| 172 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82128904 |
| 173 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.81187000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 7.54834465 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 6.59961369 |
| 3 | MP0002653_abnormal_ependyma_morphology | 6.36644533 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 5.60178831 |
| 5 | MP0002132_abnormal_respiratory_system | 4.43212058 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.65764907 |
| 7 | MP0004133_heterotaxia | 3.61393539 |
| 8 | MP0002909_abnormal_adrenal_gland | 3.56809756 |
| 9 | MP0003880_abnormal_central_pattern | 3.42356159 |
| 10 | MP0000566_synostosis | 3.41258874 |
| 11 | MP0002277_abnormal_respiratory_mucosa | 3.26063512 |
| 12 | MP0008789_abnormal_olfactory_epithelium | 3.24065796 |
| 13 | MP0009745_abnormal_behavioral_response | 3.18605796 |
| 14 | MP0002063_abnormal_learning/memory/cond | 3.11065507 |
| 15 | MP0004270_analgesia | 3.10206009 |
| 16 | MP0005646_abnormal_pituitary_gland | 3.02638795 |
| 17 | MP0005623_abnormal_meninges_morphology | 2.94275232 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.59470959 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.56338687 |
| 20 | MP0002064_seizures | 2.56228083 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 2.50361711 |
| 22 | MP0003878_abnormal_ear_physiology | 2.50361711 |
| 23 | MP0001486_abnormal_startle_reflex | 2.48944540 |
| 24 | MP0003283_abnormal_digestive_organ | 2.31042614 |
| 25 | MP0002272_abnormal_nervous_system | 2.29880216 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 2.24768725 |
| 27 | MP0001529_abnormal_vocalization | 2.23065838 |
| 28 | MP0009046_muscle_twitch | 2.15306934 |
| 29 | MP0001984_abnormal_olfaction | 2.15299531 |
| 30 | MP0005423_abnormal_somatic_nervous | 2.04541988 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.96898862 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.94112242 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.93603025 |
| 34 | MP0000383_abnormal_hair_follicle | 1.92683470 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.91816335 |
| 36 | MP0003879_abnormal_hair_cell | 1.89260545 |
| 37 | MP0010678_abnormal_skin_adnexa | 1.82489837 |
| 38 | MP0004043_abnormal_pH_regulation | 1.81896289 |
| 39 | MP0002168_other_aberrant_phenotype | 1.80599156 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.78376095 |
| 41 | MP0002160_abnormal_reproductive_system | 1.74178755 |
| 42 | MP0002282_abnormal_trachea_morphology | 1.73724373 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.70507952 |
| 44 | MP0005248_abnormal_Harderian_gland | 1.69796172 |
| 45 | MP0001970_abnormal_pain_threshold | 1.63637958 |
| 46 | MP0001188_hyperpigmentation | 1.63068188 |
| 47 | MP0002249_abnormal_larynx_morphology | 1.62256109 |
| 48 | MP0002733_abnormal_thermal_nociception | 1.61234392 |
| 49 | MP0010386_abnormal_urinary_bladder | 1.57548594 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.56630682 |
| 51 | MP0004924_abnormal_behavior | 1.56630682 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.54812191 |
| 53 | MP0005409_darkened_coat_color | 1.52360340 |
| 54 | MP0004811_abnormal_neuron_physiology | 1.50352871 |
| 55 | MP0005083_abnormal_biliary_tract | 1.49319057 |
| 56 | MP0003136_yellow_coat_color | 1.48882905 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.47096120 |
| 58 | MP0002693_abnormal_pancreas_physiology | 1.44988226 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.44698036 |
| 60 | MP0008569_lethality_at_weaning | 1.44602800 |
| 61 | MP0001440_abnormal_grooming_behavior | 1.44442668 |
| 62 | MP0003787_abnormal_imprinting | 1.42279887 |
| 63 | MP0001346_abnormal_lacrimal_gland | 1.39043641 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.31936797 |
| 65 | MP0004885_abnormal_endolymph | 1.29012295 |
| 66 | MP0001177_atelectasis | 1.28318960 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.26680553 |
| 68 | MP0003633_abnormal_nervous_system | 1.26011232 |
| 69 | MP0002736_abnormal_nociception_after | 1.25771164 |
| 70 | MP0003075_altered_response_to | 1.25104822 |
| 71 | MP0009379_abnormal_foot_pigmentation | 1.22928146 |
| 72 | MP0002735_abnormal_chemical_nociception | 1.21553555 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.19067915 |
| 74 | MP0001944_abnormal_pancreas_morphology | 1.18459971 |
| 75 | MP0002184_abnormal_innervation | 1.16737144 |
| 76 | MP0000955_abnormal_spinal_cord | 1.16677385 |
| 77 | MP0005535_abnormal_body_temperature | 1.16288017 |
| 78 | MP0002066_abnormal_motor_capabilities/c | 1.12819006 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 1.09861367 |
| 80 | MP0004085_abnormal_heartbeat | 1.08605303 |
| 81 | MP0004858_abnormal_nervous_system | 1.07207415 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 1.06479705 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.05776843 |
| 84 | MP0010030_abnormal_orbit_morphology | 1.05303344 |
| 85 | MP0000678_abnormal_parathyroid_gland | 1.02994604 |
| 86 | MP0002882_abnormal_neuron_morphology | 1.02489186 |
| 87 | MP0005395_other_phenotype | 1.02389791 |
| 88 | MP0002069_abnormal_eating/drinking_beha | 1.01031011 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 1.00619669 |
| 90 | MP0005165_increased_susceptibility_to | 1.00432812 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 1.00214440 |
| 92 | MP0002233_abnormal_nose_morphology | 0.98719319 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.97960185 |
| 94 | MP0008874_decreased_physiological_sensi | 0.94178611 |
| 95 | MP0001905_abnormal_dopamine_level | 0.92651730 |
| 96 | MP0003172_abnormal_lysosome_physiology | 0.91402449 |
| 97 | MP0000026_abnormal_inner_ear | 0.88064973 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.87931162 |
| 99 | MP0003631_nervous_system_phenotype | 0.86606951 |
| 100 | MP0005220_abnormal_exocrine_pancreas | 0.85443430 |
| 101 | MP0000569_abnormal_digit_pigmentation | 0.85053348 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 0.84661699 |
| 103 | MP0003122_maternal_imprinting | 0.84649185 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.83363066 |
| 105 | MP0006276_abnormal_autonomic_nervous | 0.83342316 |
| 106 | MP0000778_abnormal_nervous_system | 0.81205388 |
| 107 | MP0002098_abnormal_vibrissa_morphology | 0.80843808 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.80708144 |
| 109 | MP0005389_reproductive_system_phenotype | 0.80208987 |
| 110 | MP0002234_abnormal_pharynx_morphology | 0.79639818 |
| 111 | MP0003329_amyloid_beta_deposits | 0.79066235 |
| 112 | MP0001849_ear_inflammation | 0.78863454 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.78840785 |
| 114 | MP0008872_abnormal_physiological_respon | 0.78701026 |
| 115 | MP0002090_abnormal_vision | 0.77214658 |
| 116 | MP0001664_abnormal_digestion | 0.76955938 |
| 117 | MP0003698_abnormal_male_reproductive | 0.76788668 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.76231680 |
| 119 | MP0002229_neurodegeneration | 0.74838828 |
| 120 | MP0002152_abnormal_brain_morphology | 0.74641711 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.73956941 |
| 122 | MP0000681_abnormal_thyroid_gland | 0.72918253 |
| 123 | MP0004264_abnormal_extraembryonic_tissu | 0.71724205 |
| 124 | MP0009643_abnormal_urine_homeostasis | 0.71536119 |
| 125 | MP0005394_taste/olfaction_phenotype | 0.71244539 |
| 126 | MP0005499_abnormal_olfactory_system | 0.71244539 |
| 127 | MP0003690_abnormal_glial_cell | 0.70445140 |
| 128 | MP0001929_abnormal_gametogenesis | 0.70382833 |
| 129 | MP0002837_dystrophic_cardiac_calcinosis | 0.69899637 |
| 130 | MP0003300_gastrointestinal_ulcer | 0.69529406 |
| 131 | MP0005310_abnormal_salivary_gland | 0.67500018 |
| 132 | MP0003634_abnormal_glial_cell | 0.66953860 |
| 133 | MP0001293_anophthalmia | 0.66476259 |
| 134 | MP0003953_abnormal_hormone_level | 0.65749754 |
| 135 | MP0004742_abnormal_vestibular_system | 0.64881517 |
| 136 | MP0003942_abnormal_urinary_system | 0.64676618 |
| 137 | MP0002116_abnormal_craniofacial_bone | 0.64598925 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.63592445 |
| 139 | MP0001324_abnormal_eye_pigmentation | 0.63313662 |
| 140 | MP0003861_abnormal_nervous_system | 0.63247696 |
| 141 | MP0003045_fibrosis | 0.62983481 |
| 142 | MP0005253_abnormal_eye_physiology | 0.62549769 |
| 143 | MP0005195_abnormal_posterior_eye | 0.61906890 |
| 144 | MP0003137_abnormal_impulse_conducting | 0.61650534 |
| 145 | MP0002876_abnormal_thyroid_physiology | 0.60270027 |
| 146 | MP0003890_abnormal_embryonic-extraembry | 0.60210310 |
| 147 | MP0001270_distended_abdomen | 0.58933685 |
| 148 | MP0005551_abnormal_eye_electrophysiolog | 0.58775706 |
| 149 | MP0001963_abnormal_hearing_physiology | 0.58251058 |
| 150 | MP0001299_abnormal_eye_distance/ | 0.55741324 |
| 151 | MP0003938_abnormal_ear_development | 0.54994510 |
| 152 | MP0005408_hypopigmentation | 0.54614128 |
| 153 | MP0004145_abnormal_muscle_electrophysio | 0.54401909 |
| 154 | MP0005365_abnormal_bile_salt | 0.54349329 |
| 155 | MP0003303_peritoneal_inflammation | 0.53579074 |
| 156 | MP0005391_vision/eye_phenotype | 0.51356205 |
| 157 | MP0009703_decreased_birth_body | 0.51145381 |
| 158 | MP0000049_abnormal_middle_ear | 0.51142437 |
| 159 | MP0003866_abnormal_defecation | 0.49855102 |
| 160 | MP0009765_abnormal_xenobiotic_induced | 0.48746364 |
| 161 | MP0002896_abnormal_bone_mineralization | 0.47439344 |
| 162 | MP0000467_abnormal_esophagus_morphology | 0.47122564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.45581331 |
| 2 | Bronchiectasis (HP:0002110) | 7.37609735 |
| 3 | Nasal polyposis (HP:0100582) | 6.67992877 |
| 4 | Focal motor seizures (HP:0011153) | 6.63464405 |
| 5 | Abnormality of the nasal mucosa (HP:0000433) | 5.52679961 |
| 6 | Focal seizures (HP:0007359) | 4.57167220 |
| 7 | Infertility (HP:0000789) | 4.26036961 |
| 8 | Recurrent sinusitis (HP:0011108) | 4.25461773 |
| 9 | Bronchitis (HP:0012387) | 4.18890915 |
| 10 | Chronic sinusitis (HP:0011109) | 4.12104260 |
| 11 | Resting tremor (HP:0002322) | 4.10700385 |
| 12 | Male infertility (HP:0003251) | 3.92182224 |
| 13 | Visual hallucinations (HP:0002367) | 3.80969882 |
| 14 | Recurrent otitis media (HP:0000403) | 3.79730667 |
| 15 | Torticollis (HP:0000473) | 3.66828806 |
| 16 | Occipital encephalocele (HP:0002085) | 3.64369094 |
| 17 | Anxiety (HP:0000739) | 3.58814601 |
| 18 | Pancreatic fibrosis (HP:0100732) | 3.53806488 |
| 19 | True hermaphroditism (HP:0010459) | 3.44459308 |
| 20 | Action tremor (HP:0002345) | 3.41488790 |
| 21 | Ankle clonus (HP:0011448) | 3.40212053 |
| 22 | Prolonged QT interval (HP:0001657) | 3.32627359 |
| 23 | Depression (HP:0000716) | 3.28905737 |
| 24 | Febrile seizures (HP:0002373) | 3.27089315 |
| 25 | Epileptic encephalopathy (HP:0200134) | 3.24835296 |
| 26 | Papilledema (HP:0001085) | 3.23445397 |
| 27 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.21954501 |
| 28 | Absence seizures (HP:0002121) | 3.21798139 |
| 29 | Atelectasis (HP:0100750) | 3.19807914 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 3.17747184 |
| 31 | Focal dystonia (HP:0004373) | 3.17090154 |
| 32 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.14511366 |
| 33 | Poor eye contact (HP:0000817) | 3.10615183 |
| 34 | Decreased circulating renin level (HP:0003351) | 3.09916834 |
| 35 | Ankyloglossia (HP:0010296) | 3.09646190 |
| 36 | Craniofacial dystonia (HP:0012179) | 3.06171989 |
| 37 | Atonic seizures (HP:0010819) | 3.00521281 |
| 38 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.00253381 |
| 39 | Annular pancreas (HP:0001734) | 3.00224949 |
| 40 | Chronic otitis media (HP:0000389) | 2.99995843 |
| 41 | Dialeptic seizures (HP:0011146) | 2.93269246 |
| 42 | Abnormal EKG (HP:0003115) | 2.90914316 |
| 43 | Cystic liver disease (HP:0006706) | 2.87653210 |
| 44 | Pancreatic cysts (HP:0001737) | 2.77264966 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 2.77215765 |
| 46 | Molar tooth sign on MRI (HP:0002419) | 2.77215765 |
| 47 | Nephronophthisis (HP:0000090) | 2.76199318 |
| 48 | Impaired social interactions (HP:0000735) | 2.75866179 |
| 49 | Abnormal social behavior (HP:0012433) | 2.75866179 |
| 50 | Broad-based gait (HP:0002136) | 2.75626223 |
| 51 | Epileptiform EEG discharges (HP:0011182) | 2.66396048 |
| 52 | Dysdiadochokinesis (HP:0002075) | 2.65407483 |
| 53 | Stereotypic behavior (HP:0000733) | 2.62412871 |
| 54 | Abnormal pancreas size (HP:0012094) | 2.62354594 |
| 55 | EEG with generalized epileptiform discharges (HP:0011198) | 2.60613909 |
| 56 | Impaired smooth pursuit (HP:0007772) | 2.56136979 |
| 57 | Atrioventricular block (HP:0001678) | 2.54938936 |
| 58 | Truncal ataxia (HP:0002078) | 2.51538972 |
| 59 | Limb hypertonia (HP:0002509) | 2.50393967 |
| 60 | Polygenic inheritance (HP:0010982) | 2.50214432 |
| 61 | Progressive cerebellar ataxia (HP:0002073) | 2.49799787 |
| 62 | Hypsarrhythmia (HP:0002521) | 2.49776279 |
| 63 | Postural instability (HP:0002172) | 2.47109926 |
| 64 | Dysmetria (HP:0001310) | 2.46810379 |
| 65 | Postaxial foot polydactyly (HP:0001830) | 2.46486148 |
| 66 | Supranuclear gaze palsy (HP:0000605) | 2.45616513 |
| 67 | Gaze-evoked nystagmus (HP:0000640) | 2.43333903 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.42332619 |
| 69 | Bundle branch block (HP:0011710) | 2.41643392 |
| 70 | Chronic hepatic failure (HP:0100626) | 2.35471135 |
| 71 | Megalencephaly (HP:0001355) | 2.34652166 |
| 72 | Heart block (HP:0012722) | 2.33636046 |
| 73 | Abnormality of oral frenula (HP:0000190) | 2.31610917 |
| 74 | Ventricular fibrillation (HP:0001663) | 2.27814171 |
| 75 | Scanning speech (HP:0002168) | 2.26419222 |
| 76 | Unilateral renal agenesis (HP:0000122) | 2.25391026 |
| 77 | Hyperkalemia (HP:0002153) | 2.24638693 |
| 78 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.22443414 |
| 79 | Limb dystonia (HP:0002451) | 2.21071944 |
| 80 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.20638895 |
| 81 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.18565864 |
| 82 | Large for gestational age (HP:0001520) | 2.17363227 |
| 83 | Pointed chin (HP:0000307) | 2.15646240 |
| 84 | Abnormal ciliary motility (HP:0012262) | 2.13967367 |
| 85 | Abnormality of the renal medulla (HP:0100957) | 2.13408346 |
| 86 | Symptomatic seizures (HP:0011145) | 2.13179325 |
| 87 | Cortical visual impairment (HP:0100704) | 2.12746740 |
| 88 | Spinal canal stenosis (HP:0003416) | 2.12229624 |
| 89 | Bell-shaped thorax (HP:0001591) | 2.11678609 |
| 90 | Hyperventilation (HP:0002883) | 2.11306343 |
| 91 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.11277060 |
| 92 | Bradykinesia (HP:0002067) | 2.11172889 |
| 93 | Abnormal atrioventricular conduction (HP:0005150) | 2.11040372 |
| 94 | Amblyopia (HP:0000646) | 2.10814838 |
| 95 | Abnormal eating behavior (HP:0100738) | 2.09649287 |
| 96 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.08000498 |
| 97 | Impaired vibratory sensation (HP:0002495) | 2.05790233 |
| 98 | Agitation (HP:0000713) | 2.05768373 |
| 99 | Anencephaly (HP:0002323) | 2.02933211 |
| 100 | Congenital hepatic fibrosis (HP:0002612) | 2.02578376 |
| 101 | Clonus (HP:0002169) | 2.01267203 |
| 102 | Absent/shortened dynein arms (HP:0200106) | 2.00630046 |
| 103 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.00630046 |
| 104 | Spastic gait (HP:0002064) | 2.00093881 |
| 105 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 12.5000080 |
| 106 | Abnormal respiratory motile cilium morphology (HP:0005938) | 11.2911204 |
| 107 | Abnormal respiratory epithelium morphology (HP:0012253) | 11.2911204 |
| 108 | Abnormality of renin-angiotensin system (HP:0000847) | 1.99855910 |
| 109 | Tubulointerstitial nephritis (HP:0001970) | 1.99567029 |
| 110 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.97805430 |
| 111 | Intention tremor (HP:0002080) | 1.97209280 |
| 112 | Lower limb amyotrophy (HP:0007210) | 1.94740654 |
| 113 | Renal salt wasting (HP:0000127) | 1.92117909 |
| 114 | Male pseudohermaphroditism (HP:0000037) | 1.91795810 |
| 115 | Failure to thrive in infancy (HP:0001531) | 1.91198466 |
| 116 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.88254315 |
| 117 | Chronic bronchitis (HP:0004469) | 1.87325464 |
| 118 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.87322907 |
| 119 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.87322907 |
| 120 | Medial flaring of the eyebrow (HP:0010747) | 1.85555746 |
| 121 | Absent frontal sinuses (HP:0002688) | 1.83877346 |
| 122 | Dysmetric saccades (HP:0000641) | 1.83709845 |
| 123 | Rhinitis (HP:0012384) | 1.80779430 |
| 124 | Asplenia (HP:0001746) | 1.80488311 |
| 125 | Hyperactive renin-angiotensin system (HP:0000841) | 1.80191707 |
| 126 | Deep palmar crease (HP:0006191) | 1.78525182 |
| 127 | Hemiparesis (HP:0001269) | 1.78315762 |
| 128 | Incomplete penetrance (HP:0003829) | 1.77085736 |
| 129 | Gait imbalance (HP:0002141) | 1.76621724 |
| 130 | Urinary urgency (HP:0000012) | 1.76241234 |
| 131 | Increased circulating renin level (HP:0000848) | 1.75990342 |
| 132 | Neurofibrillary tangles (HP:0002185) | 1.75844689 |
| 133 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.75743050 |
| 134 | Absent eyebrow (HP:0002223) | 1.75569143 |
| 135 | Sclerocornea (HP:0000647) | 1.75481150 |
| 136 | Congenital primary aphakia (HP:0007707) | 1.74885252 |
| 137 | Abnormality of potassium homeostasis (HP:0011042) | 1.73819789 |
| 138 | Obstructive sleep apnea (HP:0002870) | 1.72222214 |
| 139 | Abnormality of the periventricular white matter (HP:0002518) | 1.71107029 |
| 140 | Furrowed tongue (HP:0000221) | 1.69552791 |
| 141 | Nephropathy (HP:0000112) | 1.66638526 |
| 142 | Postaxial hand polydactyly (HP:0001162) | 1.60257460 |
| 143 | Recurrent bronchitis (HP:0002837) | 1.60118342 |
| 144 | Tubular atrophy (HP:0000092) | 1.59348788 |
| 145 | Oculomotor apraxia (HP:0000657) | 1.58822517 |
| 146 | Hyperaldosteronism (HP:0000859) | 1.58448191 |
| 147 | Nephrogenic diabetes insipidus (HP:0009806) | 1.52795733 |
| 148 | Abnormality of chloride homeostasis (HP:0011422) | 1.46067987 |
| 149 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.40258902 |
| 150 | Hand muscle atrophy (HP:0009130) | 1.34540151 |
| 151 | Preaxial hand polydactyly (HP:0001177) | 1.33077340 |
| 152 | Short thorax (HP:0010306) | 1.32780913 |
| 153 | Fetal akinesia sequence (HP:0001989) | 1.31967500 |
| 154 | Median cleft lip (HP:0000161) | 1.29539462 |
| 155 | Abnormality of permanent molar morphology (HP:0011071) | 1.28741207 |
| 156 | Abnormality of the dental root (HP:0006486) | 1.28741207 |
| 157 | Taurodontia (HP:0000679) | 1.28741207 |
| 158 | Bifid scrotum (HP:0000048) | 1.26789684 |
| 159 | Hypokalemic alkalosis (HP:0001949) | 1.23726110 |
| 160 | Vaginal atresia (HP:0000148) | 1.20077141 |
| 161 | Genital tract atresia (HP:0001827) | 1.19475719 |
| 162 | Glucose intolerance (HP:0000833) | 1.18766924 |
| 163 | Abnormality of molar (HP:0011077) | 1.18119612 |
| 164 | Abnormality of molar morphology (HP:0011070) | 1.18119612 |
| 165 | Poor coordination (HP:0002370) | 1.17380990 |
| 166 | Hyponatremia (HP:0002902) | 1.17234687 |
| 167 | Short nail (HP:0001799) | 1.15692647 |
| 168 | Abnormality of the dental pulp (HP:0006479) | 1.14414615 |
| 169 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.13968290 |
| 170 | Tubulointerstitial abnormality (HP:0001969) | 1.13369835 |
| 171 | Short femoral neck (HP:0100864) | 1.12842024 |
| 172 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.12475120 |
| 173 | Stage 5 chronic kidney disease (HP:0003774) | 1.12339288 |
| 174 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.11297602 |
| 175 | Abnormality of the frontal sinuses (HP:0002687) | 1.10761561 |
| 176 | Decreased central vision (HP:0007663) | 1.05881517 |
| 177 | Polydipsia (HP:0001959) | 1.03760482 |
| 178 | Abnormal drinking behavior (HP:0030082) | 1.03760482 |
| 179 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.01000561 |
| 180 | Aplasia of the musculature (HP:0100854) | 1.00444089 |
| 181 | Stridor (HP:0010307) | 1.00075984 |
| 182 | Absent speech (HP:0001344) | 0.99327761 |
| 183 | Popliteal pterygium (HP:0009756) | 0.98879253 |
| 184 | Cone-rod dystrophy (HP:0000548) | 0.97669843 |
| 185 | Abnormality of dentin (HP:0010299) | 0.96237260 |
| 186 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 0.95643711 |
| 187 | Renal dysplasia (HP:0000110) | 0.93944063 |
| 188 | Distal upper limb amyotrophy (HP:0007149) | 0.93352339 |
| 189 | Upper limb amyotrophy (HP:0009129) | 0.93352339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 7.30549057 |
| 2 | MST4 | 5.15213884 |
| 3 | EPHA2 | 4.80732020 |
| 4 | NTRK3 | 4.43913665 |
| 5 | PRKD3 | 3.63217731 |
| 6 | RIPK4 | 2.71303276 |
| 7 | MAPKAPK3 | 2.57185166 |
| 8 | MAP3K9 | 2.54246978 |
| 9 | DAPK2 | 2.50167152 |
| 10 | EEF2K | 2.40766144 |
| 11 | MAP3K2 | 2.33699641 |
| 12 | NTRK1 | 2.19992360 |
| 13 | CAMKK1 | 2.19410866 |
| 14 | KSR2 | 2.07181937 |
| 15 | INSRR | 1.97785741 |
| 16 | SMG1 | 1.92279422 |
| 17 | STK24 | 1.90721269 |
| 18 | NME1 | 1.87663794 |
| 19 | EPHB1 | 1.82846090 |
| 20 | MINK1 | 1.77824999 |
| 21 | FES | 1.77229011 |
| 22 | CAMKK2 | 1.71583055 |
| 23 | MAP3K4 | 1.66502875 |
| 24 | ARAF | 1.56133039 |
| 25 | CDK5 | 1.54054069 |
| 26 | NTRK2 | 1.53946348 |
| 27 | TNIK | 1.50546663 |
| 28 | PNCK | 1.48357997 |
| 29 | PRPF4B | 1.47289169 |
| 30 | MAP3K13 | 1.44413684 |
| 31 | BMPR2 | 1.41099383 |
| 32 | CSK | 1.38978835 |
| 33 | TTK | 1.38484262 |
| 34 | SIK2 | 1.35333896 |
| 35 | DAPK1 | 1.33611756 |
| 36 | PAK6 | 1.29753625 |
| 37 | MAP2K7 | 1.28599298 |
| 38 | PRKCH | 1.26013691 |
| 39 | BCR | 1.25656551 |
| 40 | KSR1 | 1.24019885 |
| 41 | MAP3K3 | 1.20850185 |
| 42 | MARK1 | 1.17833252 |
| 43 | TAOK1 | 1.15973534 |
| 44 | MAP3K1 | 1.15940364 |
| 45 | SGK2 | 1.14945898 |
| 46 | PINK1 | 1.14560365 |
| 47 | LRRK2 | 1.13720407 |
| 48 | TESK1 | 1.13050843 |
| 49 | MARK2 | 1.12222747 |
| 50 | SGK494 | 1.11849931 |
| 51 | SGK223 | 1.11849931 |
| 52 | UHMK1 | 1.11637662 |
| 53 | EPHA3 | 1.09760285 |
| 54 | STK38 | 1.09034828 |
| 55 | HIPK2 | 1.05308487 |
| 56 | ICK | 1.04535317 |
| 57 | SGK3 | 1.00852754 |
| 58 | TRPM7 | 0.98542578 |
| 59 | PASK | 0.96819417 |
| 60 | CAMK2B | 0.95342191 |
| 61 | PRKCG | 0.93818563 |
| 62 | NEK6 | 0.90368809 |
| 63 | MAP3K7 | 0.88525125 |
| 64 | TAOK3 | 0.88516180 |
| 65 | TYRO3 | 0.84350450 |
| 66 | MAPK15 | 0.83445775 |
| 67 | RAF1 | 0.79534351 |
| 68 | PDPK1 | 0.78384739 |
| 69 | PDGFRA | 0.78275404 |
| 70 | CAMK2A | 0.77946338 |
| 71 | SGK1 | 0.77434041 |
| 72 | SIK3 | 0.76482850 |
| 73 | CAMK1 | 0.76207655 |
| 74 | ERBB2 | 0.76173351 |
| 75 | PRKCI | 0.75798789 |
| 76 | PRKD2 | 0.74865087 |
| 77 | TRIB3 | 0.74314378 |
| 78 | STK10 | 0.73976213 |
| 79 | FRK | 0.71923343 |
| 80 | CDC42BPA | 0.70719240 |
| 81 | STK11 | 0.70355662 |
| 82 | DMPK | 0.69992715 |
| 83 | GRK5 | 0.69882934 |
| 84 | RET | 0.69583712 |
| 85 | PRKCE | 0.67790484 |
| 86 | MAP2K4 | 0.67648321 |
| 87 | MST1R | 0.66760278 |
| 88 | TLK1 | 0.65145687 |
| 89 | CASK | 0.65089798 |
| 90 | PDK1 | 0.65071581 |
| 91 | BRAF | 0.60893667 |
| 92 | MAPK13 | 0.60558156 |
| 93 | WNK1 | 0.60070562 |
| 94 | AKT3 | 0.59284900 |
| 95 | RPS6KB2 | 0.58665179 |
| 96 | ERBB3 | 0.58475696 |
| 97 | CAMK2D | 0.57988815 |
| 98 | ALK | 0.56703627 |
| 99 | PTK2B | 0.56155273 |
| 100 | TNK2 | 0.55939161 |
| 101 | MAP3K12 | 0.55487179 |
| 102 | RPS6KA3 | 0.52314477 |
| 103 | TBK1 | 0.52235053 |
| 104 | CDK18 | 0.51881935 |
| 105 | MAPK10 | 0.51514252 |
| 106 | MAP2K1 | 0.50532128 |
| 107 | CDK15 | 0.50529965 |
| 108 | CDK14 | 0.49301516 |
| 109 | PRKCZ | 0.48833299 |
| 110 | PAK3 | 0.48531956 |
| 111 | RPS6KA2 | 0.48232724 |
| 112 | DYRK1B | 0.47967771 |
| 113 | FYN | 0.47286009 |
| 114 | CAMK4 | 0.44927416 |
| 115 | AURKA | 0.44888888 |
| 116 | LMTK2 | 0.44586106 |
| 117 | WNK4 | 0.43243413 |
| 118 | WNK3 | 0.43135552 |
| 119 | PRKCD | 0.43103028 |
| 120 | FGFR3 | 0.42808387 |
| 121 | PRKCQ | 0.42806903 |
| 122 | RIPK1 | 0.42488079 |
| 123 | BRSK1 | 0.40675347 |
| 124 | CDK11A | 0.40580401 |
| 125 | NLK | 0.39555831 |
| 126 | CSNK1A1 | 0.39473324 |
| 127 | STK39 | 0.38380774 |
| 128 | PRKAA2 | 0.38257781 |
| 129 | PHKG2 | 0.37528256 |
| 130 | PHKG1 | 0.37528256 |
| 131 | ROCK2 | 0.37507019 |
| 132 | PRKACA | 0.37130555 |
| 133 | PLK2 | 0.36578455 |
| 134 | PRKACG | 0.36576101 |
| 135 | CAMK2G | 0.36395514 |
| 136 | DYRK1A | 0.36295252 |
| 137 | PRKCB | 0.35426837 |
| 138 | FER | 0.33743807 |
| 139 | PRKCA | 0.33408121 |
| 140 | MAP2K2 | 0.32767323 |
| 141 | GRK6 | 0.31804179 |
| 142 | STK16 | 0.30296434 |
| 143 | MAPKAPK5 | 0.30055216 |
| 144 | ROCK1 | 0.29960174 |
| 145 | MAP3K11 | 0.29154656 |
| 146 | AKT2 | 0.26774194 |
| 147 | GRK1 | 0.25239752 |
| 148 | PTK6 | 0.24165209 |
| 149 | MAP3K6 | 0.23207007 |
| 150 | ILK | 0.21088707 |
| 151 | ADRBK1 | 0.20375706 |
| 152 | MUSK | 0.19700322 |
| 153 | STK38L | 0.19116713 |
| 154 | LATS1 | 0.18636835 |
| 155 | SRC | 0.17662920 |
| 156 | OXSR1 | 0.17270150 |
| 157 | PRKDC | 0.14320664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 5.39062653 |
| 2 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 4.97373178 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 4.50580840 |
| 4 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 4.31968600 |
| 5 | Tyrosine metabolism_Homo sapiens_hsa00350 | 4.02209555 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 4.01486315 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 3.61916807 |
| 8 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 3.06939919 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.90905360 |
| 10 | Cocaine addiction_Homo sapiens_hsa05030 | 2.77626184 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.76800761 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.70558948 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.66202818 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.52209107 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 2.51765170 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 2.48369809 |
| 17 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.44461985 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 2.39145839 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.36632460 |
| 20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.34553193 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32636318 |
| 22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.26193363 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.20689821 |
| 24 | Retinol metabolism_Homo sapiens_hsa00830 | 2.16207084 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.03869695 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.98761915 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.90439030 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87022923 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.86406331 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.86246911 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.72703903 |
| 32 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.65545179 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.65078887 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64792149 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.63501940 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63333411 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60777320 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55484441 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.54395504 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51585746 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 1.48657346 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.48334007 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.47519143 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.41992902 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39122225 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.33943377 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30405230 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.30097568 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 1.27888471 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25498685 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.23845745 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23805679 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19786732 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16523596 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 1.11960415 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11856015 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.10360275 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10121379 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07175592 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.05136811 |
| 61 | Glioma_Homo sapiens_hsa05214 | 1.03981889 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01092254 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99071020 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97542591 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.96823279 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.92430142 |
| 67 | Alcoholism_Homo sapiens_hsa05034 | 0.91201945 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90216662 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90196710 |
| 70 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.85781389 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83178154 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81057272 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78474182 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78161827 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77819321 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77809716 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77372680 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77230317 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.75182751 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74013016 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73693272 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73132922 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71817705 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71444146 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70251322 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65557400 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64811400 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62159044 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61377078 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61157293 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61031250 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60894132 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60074465 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59616332 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57380209 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57239712 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57101409 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57015674 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.56282604 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56162258 |
| 101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55625633 |
| 102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53968980 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53768125 |
| 104 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52757421 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52173456 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.51852397 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51720322 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.51404207 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.51159218 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50435021 |
| 111 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49503714 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48396668 |
| 113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47419978 |
| 114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44749235 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44412463 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44297731 |
| 117 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42923954 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40934528 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.40424967 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40398925 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.40282986 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40267772 |
| 123 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39890091 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39343954 |
| 125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38825622 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37773001 |
| 127 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35733053 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35527077 |
| 129 | Lysosome_Homo sapiens_hsa04142 | 0.34848660 |
| 130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34634101 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34030929 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33646525 |
| 133 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33371737 |
| 134 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33346142 |
| 135 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32981122 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32807470 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.32358236 |
| 138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30831626 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30217642 |
| 140 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.27332239 |
| 141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27117069 |
| 142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26648558 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25564107 |
| 144 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.24955234 |
| 145 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16805214 |
| 146 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.16426488 |
| 147 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.15534053 |

